Score Overview
Explore the 2021 public Archive ranking →
Where ADMA Biologics Inc has ranked, year by year
Showing all available years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ADMA
2019: 94.6% · 2021: 83.0% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 10.03 | — |
1 Year2025-09-30 | $ 14.66 | -31.58% |
5 Years2021-09-30 | $ 1.13 | 8x |
10 Years2016-09-30 | $ 7.24 | 38.54% |
All Time2013-10-17 | $ 8.55 | 17.31% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | All Time2013-10-17 |
|---|---|---|---|---|---|
| Price | $ 10.03 | $ 14.66 | $ 1.13 | $ 7.24 | $ 8.55 |
| Return | — | -31.58% | 8x | 38.54% | 17.31% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 512M | $ 168M | $ 136M |
| 2025 | $ 510M | $ 146M | $ 87M |
| 2024 | $ 426M | $ 197M | $ 103M |
| 2023 | $ 258M | -$ 28M | $ 51M |
| 2022 | $ 154M | -$ 65M | $ 86M |
| 2021 | $ 80M | -$ 71M | $ 51M |
| 2020 | $ 42M | -$ 75M | $ 55M |
| 2019 | $ 29M | -$ 48M | $ 26M |
| 2018 | $ 16M | -$ 65M | $ 22M |
| 2017 | $ 22M | -$ 43M | $ 43M |
| 2016 | $ 10M | -$ 19M | $ 15M |
| 2015 | $ 7M | -$ 17M | $ 16M |
| 2014 | $ 5M | -$ 16M | $ 21M |
| IPO2013 | $ 3M | -$ 15M | $ 29M |
ADMA Biologics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 42M to $ 510M and net income went from -$ 75M to $ 146M. Revenue increased in every one of those 5 years; net income in 4.
Between 2015 and 2025, revenue grew from $ 7M to $ 510M and net income went from -$ 17M to $ 146M. Revenue increased in 9 of those 10 years; net income in 6.
ADMA Biologics Inc currently holds a 5-year HDB Score of 8.5 out of 10. How the HDB Score is calculated.
Membership
Continue ADMA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
